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−18.3; −14.3) and −10.1 % (−12.3; −8.0), α-carotene by 
−14.4 % (−17.5; 11.3) and −7.8 % (−11.3; −4.3), and lyco-
pene by −12.3 % (−14.6; −10.1) and −6.3 % (−8.6; −4.0). 
Lutein concentrations decreased by −7.4 % (−10.1; −4.8), 
while TC-standardized concentrations were not changed. For 
zeaxanthin, these values were −12.9 % (−18.9; −6.8) and 
−7.7 % (−13.8; −1.7) and for β-cryptoxanthin −10.6 % 
(−14.3; −6.9) and −4.8 % (−8.7; −0.9). Non-standardized 
α-tocopherol concentrations decreased by −7.1 % (−8.0; 
−6.2) and γ-tocopherol by −6.9 % (−9.8; −3.9), while TC-
standardized tocopherol concentrations were not changed. 
Non-standardized retinol and vitamin D concentrations were 
not affected. Results were not affected by baseline concentra-
tions, dose, duration and type of plant sterols/stanols, except 
for significant effects of duration (≤4 vs. >4 weeks) on TC-
standardized lutein concentrations (1.0 vs. −5.6 %) and type 
of plant sterol/stanol on TC-standardized β-carotene concen-
trations (−8.9 vs. −14.2 %).
Conclusions Plant sterol and stanol intake lowers TC-
standardized hydrocarbon carotenoid concentrations, 
differently affects TC-standardized oxygenated carot-
enoid concentrations, but does not affect TC-standardized 
tocopherol concentrations or absolute retinol and vitamin D 
concentrations. Observed concentrations remained within 
normal ranges.
Keywords Plant sterols · Plant stanols · Cholesterol · 
Hydrocarbon carotenoids · Oxygenated carotenoids · Fat-
soluble vitamins
Introduction
Numerous studies have shown that consuming plant sterol- 
or plant stanol-enriched foods (0.6–3.3 g sterols or stanols/
Abstract 
Purpose Plant sterols and stanols interfere with intestinal 
cholesterol absorption, and it has been questioned whether 
absorption and plasma concentrations of fat-soluble vita-
mins and carotenoids are also affected. We conducted a 
meta-analysis to assess the effects of plant sterol and stanol 
consumption on plasma fat-soluble vitamin and carotenoid 
concentrations.
Methods Forty-one randomized controlled trials involv-
ing 3306 subjects were included. Weighted absolute and 
relative changes of non-standardized and total cholesterol 
(TC)-standardized values (expressed as summary estimates 
and 95 % CIs) were calculated for three fat-soluble vita-
mins (α- and γ-tocopherol, retinol and vitamin D) and six 
carotenoids (β-carotene, α-carotene, lycopene, lutein, zeax-
anthin and β-cryptoxanthin) using a random effects model. 
Heterogeneity was assessed using predefined subject and 
treatment characteristics.
Results Average plant sterol or stanol intake was 2.5 g/d. Rel-
ative non-standardized and TC-standardized concentrations 
of β-carotene decreased by, respectively, −16.3 % (95 % CI 
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day) lowers plasma or serum low-density lipoprotein cho-
lesterol (LDL-C) concentrations by 6−12 % [1–3]. Since 
plant sterols and plant stanols interfere with intestinal cho-
lesterol absorption and consequently affect whole-body 
lipid and lipoprotein metabolism [4], questions have been 
raised whether plasma fat-soluble vitamin and carotenoid 
concentrations are also affected by plant sterol and stanol 
consumption. A reduction in plasma fat-soluble vitamin 
and carotenoid concentrations may be undesirable, since in 
prospective cohort studies lower concentrations have been 
associated with an increased risk of several chronic dis-
eases, such as cardiovascular diseases (CVDs), cancer and 
age-related macular degeneration (AMD) [5–7], although 
evidence from randomized controlled trials is lacking [8, 9].
Already in 2003, Katan et al. [10] performed a meta-
analysis including 18 studies and showed significant reduc-
tions in circulating α-tocopherol, α-carotene, β-carotene 
and lycopene concentrations after plant sterol and stanol 
ester consumption. Concentrations of the fat-soluble vita-
mins retinol and vitamin D were not affected. However, 
when concentrations were standardized for serum total 
cholesterol (TC) concentrations, there were no longer 
decreases in α-tocopherol, α-carotene and lycopene con-
centrations, while β-carotene concentrations remained 
significantly reduced with a mean reduction of 12 %. This 
implies that at least for some of the vitamins and carote-
noids decreases are related to the reduction in the number 
of circulating lipoproteins, the carriers of the fat-soluble 
tocopherols and carotenoids. However, it has also been sug-
gested that plant sterols and stanols reduce the incorpora-
tion of the more lipophilic hydrocarbon carotenoids (i.e., 
β-carotene, α-carotene and lycopene) into the micelles to 
a greater extent than those of the less lipophilic oxygenated 
carotenoids (lutein, zeaxanthin and β-cryptoxanthin) and 
tocopherols [11]. Finally, plant sterol and plant stanol con-
sumption might not affect vitamins that require a specific 
transporter instead of the lipoprotein-mediated transport 
route, such as retinol and vitamin D.
Recently, Fardet et al. [12] have summarized the effects 
of plant sterols and plant stanols on fat-soluble vitamin 
and carotenoid concentrations. They calculated median 
relative changes (standardized and non-standardized) in 
α-tocopherol, γ-tocopherol, α-carotene, β-carotene and 
β-cryptoxanthin concentrations. However, results seem 
biased as only studies were included that reported signifi-
cant reductions in plasma fat-soluble vitamin and carot-
enoid concentrations. In addition, a detailed description of 
the systematic approach to review the available literature 
was lacking. Therefore, to provide an up-to-date quanti-
tated overview on the effects of plant sterol or plant stanol 
consumption on plasma fat-soluble vitamin and carot-
enoid concentrations, we performed a meta-analysis of 
randomized controlled trials (RCTs). For this, absolute 
and relative changes were estimated for three fat-soluble 
vitamin (α- and γ-tocopherol, retinol and vitamin D) and 
six carotenoid (β-carotene, α-carotene, lycopene, lutein, 
zeaxanthin and β-cryptoxanthin) concentrations after plant 
sterol or plant stanol consumption. Furthermore, potential 
sources of heterogeneity between studies were assessed by 
investigating the impact of predefined subject and treat-
ment characteristics on changes in plasma fat-soluble vita-
min and carotenoid concentrations.
Methods
Search strategy
Potentially relevant studies were retrieved by a systematic 
search of five databases (Medline, Embase, the Cochrane 
Library, Cab abstracts and Food, Science and Technology 
abstracts) in December 2014. A search strategy was devel-
oped including the Medical Subject Heading ‘phytosterols’ 
and the following search terms: (plant sterol* or phytos-
terol* or sitosterol* or campesterol* or stigmasterol* or 
brassicasterol* or plant stanol* or sitostanol* or camp-
estanol*) and (vitamin* or carotene* or carotenoid* or 
tocotrienol* or tocopherol* or alpha-carotene* or beta-car-
otene* or lycopene* or lutein* or zeaxanthin* or retinol* or 
calciferol*), limited to humans without any restriction on 
language. Throughout this paper, the term ‘plasma’ is used, 
irrespective whether plasma or serum concentrations were 
reported in the different studies.
Selection of studies
Human intervention studies were considered eligible if 
effects of plant sterol or plant stanol consumption on 
plasma fat-soluble vitamin or carotenoid concentra-
tions were reported. In the first selection round, titles and 
abstracts were screened and studies were selected if they 
met the following inclusion criteria: (1) RCT in humans 
(studies with children were allowed), (2) oral intake of 
plant sterol- or plant stanol-enriched foods or supplements, 
(3) measurement of plasma fat-soluble vitamins or carot-
enoids, (4) no co-intervention next to the plant sterol or 
plant stanol intervention, (5) no studies in phytosterolemic 
patients, (6) duration of at least 2 weeks and (7) no dupli-
cates. For the second selection round, full publications 
were read to assess their eligibility. Studies were excluded 
when they lacked a control group or were not randomized, 
when an intentional co-intervention (e.g., extra vitamins) 
was given that could not be separated from the effects of 
the plant sterol or plant stanol intervention or when plasma 
fat-soluble vitamin or carotenoid concentrations were not 
reported. Studies evaluating the effects of ferulated plant 
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sterols (as in shea nut oil) were not included, since they are 
not commonly used in currently commercially available 
plant sterol- and stanol-enriched foods and there is no con-
sensus on their cholesterol-lowering effects [13, 14]. When 
inconclusive, the eligibility of studies was discussed among 
authors until consensus was reached.
Data extraction and transformation
Data were collected using a database that included (1) publi-
cation characteristics (reference number, first author and year 
of publication), (2) study characteristics (parallel or crosso-
ver design, sample size and study duration), (3) subject char-
acteristics (health status, mean age, mean BMI and gender 
distribution), (4) treatment characteristics (use of plant ster-
ols or plant stanols, dose of plant sterols or plant stanols 
and food format), (5) measurement characteristics (serum 
or plasma) and (6) outcome variables [plasma and serum 
concentrations of α-carotene, β-carotene, α-tocopherol, 
γ-tocopherol, lutein, zeaxanthin, β-cryptoxanthin, lycopene, 
vitamin D, retinol, TC, LDL-C, high-density lipoprotein 
cholesterol (HDL-C) and triacylglycerols (TAG)].
For all outcome variables, mean concentrations and 
accompanying variance measures were extracted at base-
line and at the end of the intervention. In the circulation, 
tocopherols and carotenoids are transported by lipoprotein 
particles and therefore often standardized for serum cho-
lesterol concentrations. Since vitamin D and retinol are 
not transported by lipoproteins, they were solely expressed 
as non-standardized concentrations. To unify the use of 
all cholesterol-standardized tocopherol and carotenoid 
concentrations, absolute TC data were extracted and TC-
standardized tocopherol and carotenoid concentrations 
were calculated by dividing the absolute tocopherol/carot-
enoid concentrations at baseline and at end of intervention 
by the respective TC concentrations. Original authors were 
contacted for non-standardized tocopherol and carotenoid 
concentrations if only cholesterol-standardized levels were 
reported [15–19].
Cholesterol data (TC, LDL-C and HDL-C) and TAG 
data expressed in mg/dL were converted into mmol/L by 
using their molecular weights (386.7 and 885.7 g/mol, 
respectively). In case fat-soluble vitamin or carotenoid con-
centrations were expressed in ng/mL, ng/dL, μg/mL, μg/
dL, μg/L, mg/dL, mg/L, g/mL, these data were also trans-
formed based on their molecular weights to derive concen-
trations in μmol/L or nmol/L (g/mol for α- and β-carotene: 
536.9, α-tocopherol: 430.7, γ-tocopherol: 416.7, lutein 
and zeaxanthin: 568.9; β-cryptoxanthin: 552.9, lycopene: 
536.9, retinol: 286.5 and vitamin D: 400.6). These transfor-
mations were done for means and for SEs or SDs.
Placebo-adjusted absolute and relative changes with 
accompanying SEs were calculated for α-carotene, 
β-carotene, α-tocopherol, γ-tocopherol, lutein, zeaxanthin, 
β-cryptoxanthin, lycopene, vitamin D, retinol, TC, LDL-
C, HDL-C and TAG for each study (when data were avail-
able). For parallel studies, absolute and relative changes 
(with accompanying SEs) were calculated based on average 
concentrations and variance measures at baseline and at end 
of intervention of treatment and control groups. For crosso-
ver studies, absolute and relative changes were calculated 
based on concentrations at end of intervention of treatment 
and control periods. In case it was not possible to calculate 
placebo-adjusted changes and SEs, these data were used 
as reported in the papers [16, 20–25]. Data expressed as 
median (minimum, maximum) values were transformed to 
means ± SDs using the method of Wan et al. [26, 27] and 
data displayed in graphs were extracted using ScanIt ver-
sion 1.0 [23, 28–31]. To derive SE from 95 % CI [13, 14] 
or from an effect estimate and P value [20], equations were 
used as described by the Cochrane handbook for system-
atic reviews of interventions [32]. The Friedewald equation 
[33] was used for one study [34] to estimate the TC con-
centration based on the reported concentrations of LDL-C, 
HDL-C and TG. In case only TC-standardized data were 
available, these data were added in SAS [23].
Statistical analysis
For each outcome parameter, a weighted net effect 
(expressed as summary estimate and 95 % CI) was calcu-
lated using a random effects model and the inverse of the 
within-study variance (1/SE2) was used as weighing factor 
[35]. These effects were calculated for baseline concen-
trations, end-of-intervention concentrations, absolute and 
relative changes of non-standardized and TC-standardized 
values. For interpretation of the data, the various outcome 
parameters were clustered in hydrocarbon or oxygenated 
carotenoids, in fat-soluble vitamins or plasma lipids. For-
est plots were made for relative changes in representa-
tives of the three fat-soluble vitamin/carotenoid categories 
(β-carotene representing the hydrocarbon carotenoids, 
lutein the oxygenated carotenoids and α-tocopherol the 
tocopherols).
Funnel plots were created to visualize the likeliness of 
heterogeneity (in case many effect sizes fall outside the 
confidence limits) and publication bias (in case of asym-
metry). Heterogeneity was assessed using Cochran’s Q test 
(P < 0.1 indicates significant heterogeneity) and quantified 
by I2, which indicates the percentage of variability in effect 
estimate that is due to heterogeneity rather than sampling 
error [35, 36]. Publication bias was evaluated by Egger’s 
weighted regression test where the absence of publication 
bias is reflected by an intercept close to 0 (P ≥ 0.05) [37].
Subgroup analyses were performed for β-carotene, 
lutein and α-tocopherol as representatives of the 
912 Eur J Nutr (2017) 56:909–923
1 3
hydrocarbon carotenoids, oxygenated carotenoids and 
tocopherols to evaluate whether TC-standardized absolute 
and relative changes were influenced by predefined subject 
characteristics (i.e., baseline concentrations of β-carotene, 
lutein and α-tocopherol) or treatment characteristic (i.e., 
use of plant sterols or plant stanols, dose of plant sterols or 
plant stanols and duration of intervention). Subgroup anal-
yses were also performed for effects on TC. Subgroups 
were defined using the median baseline concentrations and 
the median duration (4 weeks) as cut-offs. For the dose 
categories, we used 1.6, 2.0, 3.0 and 9.0 g/d as cut-offs 
allowing a more or less equal distribution of studies across 
the four dose categories.
Results were considered to be statistically significant if 
P < 0.05 based on two-sided testing. All statistical analyses 
were performed using SAS version 9.4 (SAS institute Inc., 
Cary, NC, USA). Forest plots were created using STATA 
version 12.1 (STATA Corporation, College Station, TX, 
USA). This meta-analysis adheres to the PRISMA state-
ment guidelines for reporting in systematic reviews and 
meta-analyses.
Results
Overview of included studies
The systematic search retrieved 1084 potentially relevant 
papers, and after two selection rounds, 41 RCTs were 
included in the meta-analysis. A flowchart of the study 
selection process is presented in Fig. 1.
Of the 41 included studies (Online Supplemental Mate-
rial Tables 1 and 2), 23 were conducted as a parallel study 
[15–17, 19, 21–26, 28–31, 34, 38–45] and 18 studies had a 
crossover design [13, 14, 18, 20, 46–59]. In total, 3306 sub-
jects participated with an average age of 47.6 years (range 
10.5–61.8 years) and an average BMI of 25.1 kg/m2 (range 
19.0–28.3 kg/m2). The median study duration was 28 days 
(range 21–364 days) with an average dose of 2.5 g/d (range 
0.45–9.0 g/d), and 80 % of the studies were performed with 
esterified plant sterols or plant stanols.
Plasma fat‑soluble vitamin/carotenoid outcomes
The weighted effects of plant sterol or plant stanol con-
sumption on plasma fat-soluble vitamin and carotenoid 
concentrations are presented in Table 1. Non-standardized 
and TC-standardized hydrocarbon carotenoid concen-
trations, i.e., lycopene, α-carotene and β-carotene, were 
significantly (P < 0.0001) lowered after consumption of 
plant sterol- or plant stanol-enriched foods. β-Carotene 
concentrations decreased on average by 0.08 µmol/L 
(−16.3 %; −10.1 % when TC-standardized), α-carotene 
concentrations by 0.02 µmol/L (−14.4 %; −7.8 % 
when TC-standardized) and lycopene concentrations by 
−0.04 µmol/L (−12.3 %; −6.3 % when TC-standardized). 
For the oxygenated carotenoids, i.e., lutein, zeaxanthin and 
β-cryptoxanthin, non-standardized concentrations were 
significantly (P < 0.0001) lowered, while changes in TC-
standardized concentrations showed less conclusive results. 
Lutein concentrations decreased on average by 0.02 µmol/L 
(−7.4 %), while the TC-standardized concentrations in 
Fig. 1  Flowchart study selec-
tion process. The literature 
search retrieves 1084 poten-
tially relevant papers, 1009 
are excluded after screening 
titles and abstracts, 75 articles 
are reviewed in full and 41 
randomized controlled trials 
(RCTs) are included in the 
meta-analysis
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lutein were not significantly changed (−1.5 %) after plant 
sterol or plant stanol consumption. Non-standardized zeax-
anthin concentrations decreased on average by 7.81 nmol/L 
(−12.9 %; −7.7 % when TC-standardized (P < 0.05)) and 
β-cryptoxanthin decreased by −0.03 µmol/L [−10.6 %; 
−4.8 % when TC-standardized (P < 0.05)]. Non-standard-
ized tocopherol concentrations significantly (P < 0.0001) 
decreased after plant sterol or plant stanol consumption 
(α-tocopherol on average by 2.43 µmol/L (−7.1 %) and 
γ-tocopherol by 0.17 µmol/L (−6.9 %). However, when 
standardized for TC concentrations, α- and γ-tocopherol 
concentrations were no longer changed after plant sterol 
or plant stanol consumption (−0.3 and 0.2 %, respectively; 
P > 0.05). Concentrations of retinol and vitamin D were 
not changed after plant sterol or plant stanol consumption 
(−0.8 and 1.4 %, respectively; P > 0.05).
TC concentrations were significantly (P < 0.0001) 
decreased on average by 0.39 mmol/L (−6.5 %) and 
LDL-C concentrations by 0.35 mmol/L (−9.0 %). HDL-C 
concentrations did not change after plant sterol or plant 
stanol consumption (0.2 %), while TAG concentrations 
were significantly (P < 0.0001) decreased by 0.06 mmol/L 
(−4.6 %) (Table 1).
Figures 2, 3 and 4 show forest plots of the relative non-
standardized and TC-standardized changes for β-carotene, 
lutein and α-tocopherol. Funnel plots for the relative non-
standardized and TC-standardized changes in β-carotene, 
lutein and α-tocopherol are shown in Online Supplemen-
tal Material Figs. 1–3. Visual inspection and calculation of 
I2 statistics (P < 0.05) indicated substantial heterogeneity 
in the relative non-standardized changes of α-tocopherol. 
Heterogeneity was also present for relative non-standard-
ized changes of zeaxanthin and lycopene and for the rela-
tive TC-standardized changes of α-carotene and zeaxanthin 
(data not shown). Publication bias seemed only present for 
α-carotene (Egger test: P (intercept) < 0.05; studies report-
ing small decreases in plasma changes seemed lacking, 
data not shown).  
Covariate analyses
Table 2 provides an overview of the covariate analyses 
for the TC-standardized changes in β-carotene, lutein, 
α-tocopherol (β-carotene representing the hydrocar-
bon carotenoids, lutein the oxygenated carotenoids and 
α-tocopherol the tocopherols) and for TC concentrations. 
Overall, baseline concentrations did not have a signifi-
cant impact on the observed changes after plant sterol or 
plant stanol consumption. Only some trends were observed 
implying larger absolute reductions in β-carotene and 
larger absolute and relative reductions in α-tocopherol 
with higher baseline values. Furthermore, the plant sterol 
or plant stanol dose did not significantly affect TC-stand-
ardized absolute or relative changes in β-carotene, lutein 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.592)
Deveraj et al., 2006
Carr et al., 2009
Mensink et al., 2010 stratum 3
Noakes et al., 2005 stratum 2
Christiansen et al., 2001 stratum 2
Ntanios et al., 2002
Christiansen et al., 2001 stratum 1
Plat et al., 2001 stratum 2
Hallikainen et al., 2000b stratum 1
Judd et al., 2002
Korpela et al., 2006
Hallikainen et al., 2000a stratum 1
Noakes et al., 2005 stratum 1
Mensink et al., 2010 stratum 1
Plat et al., 2000 stratum 2
Seki et al., 2003a
ID
Gylling et al., 2010
Study
Hallikainen et al., 2000a stratum 3
Hallikainen et al., 2000a stratum 2
Hallikainen et al., 2000a stratum 4
Clifton et al., 2004b stratum 2
Hallikainen et al., 1999 stratum 2
Davidson et al., 2001 stratum 2
Seki et al., 2003b
Hallikainen et al., 2000b stratum 2
Rudkowska et al., 2008b stratum 1
Hansel et al., 2007
Rudkowska et al., 2008b stratum 2
Plat et al., 2000 stratum 1
Maki et al., 2001 stratum 1
Plat et al., 2001 stratum 1
Colgan et al., 2004
Mensink et al., 2002
Heggen et al., 2010 stratum 2
Hernandez-Mijares et al., 2010
Amundsen et al., 2002
Hallikainen et al., 1999 stratum 1
Homma et al., 2003 stratum 1
Noakes et al., 2005 stratum 3
Hendriks et al., 2003
Davidson et al., 2001 stratum 1
Clifton et al., 2004b stratum 1
Gylling et al., 1999a
Mensink et al., 2010 stratum 2
Thomsen et al., 2004 stratum 1
Heggen et al., 2010 stratum 1
Kriengsinyos et al., 2011
Homma et al., 2003 stratum 2
Davidson et al., 2001 stratum 3
Maki et al., 2001 stratum 2













































































































NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.657)
Homma et al., 2003 stratum 1
Plat et al., 2000 stratum 2
Nguyen et al., 1999b stratum 2
Mensink et al., 2002
Mensink et al., 2010 stratum 1
ID
Clifton et al., 2004b stratum 1
Seki et al., 2003b
Ntanios et al., 2002
Hallikainen et al., 1999 stratum 1
Mensink et al., 2010 stratum 3
Hendriks et al., 2003
Hernandez-Mijares et al., 2010
Nguyen et al., 1999b stratum 1
Plat et al., 2001 stratum 1
Noakes et al., 2005 stratum 1
Korpela et al., 2006
Noakes et al., 2005 stratum 3
Davidson et al., 2001 stratum 3
Hallikainen et al., 2000b stratum 1
Seki et al., 2003a
Davidson et al., 2001 stratum 2
Heggen et al., 2010 stratum 1
Kriengsinyos et al., 2011
Hallikainen et al., 2000a stratum 3
Hansel et al., 2007
Nguyen et al., 1999b stratum 3
Thomsen et al., 2004 stratum 1
Christiansen et al., 2001 stratum 2
Rudkowska et al., 2008b stratum 1
Hallikainen et al., 2000b stratum 2
Plat et al., 2001 stratum 2
Colgan et al., 2004
Hallikainen et al., 2000a stratum 2
Gylling et al., 2010
Christiansen et al., 2001 stratum 1
Noakes et al., 2005 stratum 2
Deveraj et al., 2006
Hallikainen et al., 2000a stratum 4
Carr et al., 2009
Mensink et al., 2010 stratum 2
Amundsen et al., 2002
Davidson et al., 2001 stratum 1
Maki et al., 2001 stratum 1
Gylling et al., 1999a
Rudkowska et al., 2008b stratum 2
Clifton et al., 2004b stratum 2
Hallikainen et al., 2000a stratum 1
Maki et al., 2001 stratum 2
Thomsen et al., 2004 stratum 2
Heggen et al., 2010 stratum 2
Plat et al., 2000 stratum 1
Judd et al., 2002
Hallikainen et al., 1999 stratum 2
Study



















































































































Fig. 2  Forest plot relative change (expressed as summary estimates 
and 95 % CIs) in non-standardized (left panel) and TC-standardized 
(right panel) plasma β-carotene concentrations. The solid squares 
represent the weight of individual study arms, and the pooled effect 
estimate is represented as a diamond. Heterogeneity is assessed using 
Cochran’s Q test (P < 0.1 indicates significant heterogeneity) and 
quantified by I2, where >50 % indicates substantial heterogeneity
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and α-tocopherol. Only study duration (≤4 vs. >4 weeks) 
resulted in larger TC-standardized absolute and relative 
reductions in lutein (0.000 vs. −0.002 µmol/mmol TC 
and 1.0 vs. −5.6 %, respectively), whereas only a trend 
for such effect was observed for β-carotene. Consump-
tion of plant stanols seemed to have a stronger effect on 
lowering relative TC-standardized β-carotene concentra-
tions than plant sterols (−14.2 vs. −8.9 %, respectively), 
while changes in α-tocopherol concentrations showed a 
trend toward larger reductions after plant stanol vs. sterol 
consumption. Changes in TC concentrations were also 
larger after consumption of plant stanols vs. plant sterols 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 19.0%, p = 0.209)
Deveraj et al., 2006
Thomsen et al., 2004 stratum 2
ID
Maki et al., 2001 stratum 2
Mensink et al., 2010 stratum 1
Davidson et al., 2001 stratum 1
Colgan et al., 2004
Amundsen et al., 2002
Mensink et al., 2010 stratum 3
Mensink et al., 2010 stratum 2
Thomsen et al., 2004 stratum 1
Davidson et al., 2001 stratum 2
Rudkowska et al., 2008b stratum 2
Clifton et al., 2004b stratum 1
Clifton et al., 2004b stratum 2
Maki et al., 2001 stratum 1
Noakes et al., 2005 stratum 3
Noakes et al., 2005 stratum 1
Study
Hernandez-Mijares et al., 2010
Hendriks et al., 2003
Rudkowska et al., 2008b stratum 1
Davidson et al., 2001 stratum 3



















































NOTE: Weights are from random effects analysis
Overall  (I-squared = 29.0%, p = 0.101)
Deveraj et al., 2006
Rudkowska et al., 2008b stratum 1
Thomsen et al., 2004 stratum 2
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Fig. 3  Forest plot relative change (expressed as summary estimates 
and 95 % CIs) in non-standardized (left panel) and TC-standardized 
(right panel) plasma lutein concentrations. The solid squares repre-
sent the weight of individual study arms, and the pooled effect esti-
mate is represented as a diamond. Heterogeneity is assessed using 
Cochran’s Q test (P < 0.1 indicates significant heterogeneity) and 
quantified by I2, where >50 % indicates substantial heterogeneity
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Fig. 4  Forest plot relative change (expressed as summary estimates 
and 95 % CIs) in non-standardized (left panel) and TC-standardized 
(right panel) plasma α-tocopherol concentrations. The solid squares 
represent the weight of individual study arms, and the pooled effect 
estimate is represented as a diamond. Heterogeneity is assessed using 
Cochran’s Q test (P < 0.1 indicates significant heterogeneity) and 
quantified by I2, where >50 % indicates substantial heterogeneity
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(−8.0 vs. −6.1 %, respectively), which is probably related 
to a higher dose in the plant stanol compared to the plant 
sterol studies (3.2 vs. 2.1 g/d). In addition, changes in TC 
concentrations after plant sterol or plant stanol consump-
tion were significantly affected by baseline concentrations 
(only absolute TC changes) and by the dose of plant sterol 
or plant stanol intake.
Discussion
Although there is general consensus about the serum cho-
lesterol-lowering efficacy of consuming foods enriched 
with plant sterols and stanols, there is an ongoing discus-
sion around the potential effects of these ingredients on 
plasma fat-soluble vitamin and carotenoid concentrations. 
Therefore, we here present the first extensive systematic 
review and meta-analysis to estimate the effects of plant 
sterol and plant stanol consumption on plasma fat-soluble 
vitamin and carotenoid concentrations. We observed a 
decrease in non-standardized (hydrocarbon and oxygen-
ated) carotenoids and in tocopherol concentrations, but not 
in vitamin D and retinol concentrations. TC-standardized 
concentrations remained significantly decreased for all 
individual hydrocarbon carotenoids, while the oxygen-
ated carotenoid concentrations were differently affected 
and TC-standardized tocopherol concentrations were not 
changed after plant sterol and plant stanol consumption.
In an earlier less extensive review from 2003 by Katan 
et al. [10] including eighteen studies, a reduction in TC-
standardized β-carotene was found, while TC-standard-
ized concentrations of α-carotene, lycopene, α-tocopherol 
and absolute concentrations of vitamin D and retinol were 
not affected by plant sterol and plant stanol consumption. 
Our data based on 41 studies available in December 2014 
are partly in agreement with these earlier findings, since 
we observed a significant decrease in all TC-standardized 
hydrocarbon carotenoid concentrations, while Katan et al. 
only reported a significant decrease in TC-standardized 
β-carotene but not in TC-standardized α-carotene and lyco-
pene concentrations.
Regarding the interpretation of changes in absolute fat-
soluble vitamin and carotenoid concentrations, it needs to 
be emphasized that these components are transported by 
lipoproteins (except retinol and vitamin D) [60, 61]. There-
fore, a reduction in non-standardized concentrations might 
be the result of reduced carrier capacity, as evidenced by 
lower serum cholesterol concentrations after plant sterol 
or plant stanol intake. For this reason, fat-soluble vitamin 
and carotenoid concentrations are generally standardized 
for various plasma lipid fractions. We chose to standardize 
for TC (reflecting cholesterol in all lipoproteins), since fat-
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in one lipoprotein fraction. After standardization for TC, α- 
and γ-tocopherol concentrations were not changed, while 
changes in oxygenated carotenoids became less significant 
(zeaxanthin and β-cryptoxanthin) or were no longer present 
(lutein). Reductions in TC-standardized concentrations for 
all hydrocarbon carotenoids (β-carotene, α-carotene and 
lycopene) remained significant although relative changes 
were smaller compared with the non-standardized changes. 
This suggests that reductions in non-standardized tocoph-
erol concentrations can primarily be explained by a reduc-
tion in the number of lipoprotein particles, while changes 
in non-standardized carotenoid concentrations can only 
partly be explained by a decrease in carrier capacity. For 
the lipophilic hydrocarbon carotenoids, other factors should 
be considered to explain the observed reductions. Analog to 
cholesterol, plant sterol and plant stanols, fat-soluble vita-
mins and carotenoids are lipophilic compounds that require 
solubilization into mixed micelles for intestinal absorp-
tion [60, 61]. Plant sterols and plant stanols interfere with 
micellar sterol composition and probably also interact with 
incorporation of fat-soluble vitamins and carotenoids in the 
micelles. This seems particularly evident for the more lipo-
philic hydrocarbon carotenoids for which the largest reduc-
tions in serum concentrations were found after plant sterol 
or plant stanol intake. Indeed, Plat and Mensink [19] have 
shown that changes in hydrocarbon (but not in oxygenated) 
carotenoid concentrations were significantly related to 
reductions in markers of cholesterol absorption after plant 
stanol consumption.
Subgroup analyses showed a stronger reduction in rela-
tive TC-standardized β-carotene concentrations and a trend 
toward larger reductions in TC-standardized α-tocopherol 
concentrations after plant stanol consumption as compared 
with plant sterol consumption. Changes in TC concentra-
tions were also larger after consumption of plant stanols 
compared with plant sterols. Plant stanol studies inves-
tigated overall higher doses (3.2 vs. 2.1 g/d with plant 
sterols), which probably explains the larger TC-lowering 
efficacy. Indeed, subgroup analyses indicated that TC con-
centrations decreased dose dependently. Even though a 
dose–response effect was lacking for relative TC-standard-
ized β-carotene concentrations, largest decreases were seen 
in the highest dose category (3.0 < dose ≤ 9.0 g/d). As plant 
stanol studies investigated overall higher doses, the differ-
ence between plant sterol and stanol studies on relative TC-
standardized β-carotene concentrations might be explained 
by a difference in average dose. Nevertheless, this is still an 
unexpected finding and a side-by-side comparison would 
be needed to evaluate a difference between plant sterols 
and plant stanols on serum β-carotene concentrations in 
more detail. Baseline concentrations as well as the dura-
tion of the interventions did not have a major impact on 
plasma fat-soluble vitamin and carotenoid concentrations 
after plant sterol or plant stanol consumption. In addition, 
as already mentioned, a clear dose–response effect was 
lacking for fat-soluble vitamin and carotenoid concentra-
tions, while TC concentrations decreased dose depend-
ently after plant sterol or plant stanol consumption. Such 
a dose-dependent cholesterol lowering has been shown by 
Mensink et al. [16], where a linear dose–response relation-
ship was reported for plant stanol intake and cholesterol 
decrease up to 9 g/d. A dose–response relationship for the 
reduction in LDL-C at least up to intakes of 3 g/d of plant 
sterols and stanols was also found in the meta-analysis of 
Ras et al. [3].
Whether the observed reductions in plasma tocopherols 
and especially carotenoid concentrations are clinically rel-
evant is not known. In fact, ranges of plasma fat-soluble 
vitamin and carotenoid concentrations that are defined 
as normal are very wide [62, 63]. The Food and Nutri-
tion Board of the Health and Medicine Division reported, 
based on data of more than 20.000 subjects who partici-
pated in the NHANES 1988–1994 [64], an average plasma 
β-carotene concentration of 0.35 μmol/L, and 95 % of the 
subjects had values between 0.10 and 0.86 μmol/L. We 
observed that β-carotene was reduced from 0.60 μmol/L 
(95 % CI 0.54; 0.67) to 0.52 μmol/L (95 % CI 0.46; 0.57) 
after plant sterol and plant stanol consumption; thus, 
β-carotene concentrations remained within normal ranges. 
In addition, they reported [64] average concentrations 
of α-carotene 0.09 (0.02–0.23) μmol/L, β-cryptoxanthin 
0.17 (0.06–0.36) μmol/L and lycopene 0.44 (0.18–0.76) 
μmol/L. Lutein and zeaxanthin were reported together with 
an average concentration of 0.37 (0.17–0.68) μmol/L. Our 
observed carotenoid concentrations remained within these 
reported ranges after plant sterol and plant stanol con-
sumption. Ford et al. [65] reported a mean α-tocopherol 
concentration of 27.4 (95 % CI 26.7; 28.1) μmol/L and a 
mean γ-tocopherol concentration of 4.8 (95 % CI 4.5; 5.1) 
μmol/L in >4000 subjects who participated in NHANES 
1999–2000. We observed overall higher α-tocopherol con-
centrations and lower γ-tocopherol concentrations, which 
can be explained by a higher intake of γ-tocopherol in the 
US diet compared to a higher α-tocopherol intake in the 
European diet. Nevertheless, our observed total tocopherol 
concentration (α- and γ-tocopherol) after plant sterol and 
stanol intake remained within ranges as presented for 450 
healthy subjects [63] with a median value of 28.6 (18.4–
46.0) μmol/L and >20.000 subjects who participated in 
NHANES 1988–1994 with a mean concentration of 25.3 
(14.6–43.6) μmol/L [64].
For CVD, the overall notion is that a healthy diet with 
high intakes of fruit and vegetables may lower the risk to 
develop CVD. Whether this effect is related to antioxi-
dants is not known, also because clinical trials do not sup-
port a causal role for antioxidant supplementation in the 
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prevention of chronic diseases such as CVD [8, 9]. In con-
trast, some prospective cohort studies have reported inverse 
associations between absolute carotenoid concentrations 
and the risk to develop CVD or cancers [5, 7, 66], although 
such relationships have not been observed in all studies [67, 
68]. In addition, associations do not imply causality, com-
plicating the interpretation of decreased plasma carotenoid 
concentrations after plant sterol or stanol consumption. 
Except for a possible role as antioxidant, it is well estab-
lished that carotenoids (particularly β-carotene) are a pre-
cursor for the synthesis of vitamin A [69]. However, serum 
vitamin A (retinol) concentrations were not changed after 
plant sterol or plant stanol intake. A more consistent asso-
ciation is present for dietary lutein and zeaxanthin intake, 
where higher plasma concentrations are associated with a 
reduced risk to develop advanced AMD [6]. Although data 
are limited, active modulation of plasma lutein concentra-
tions by supplementation may also affect AMD and CVD 
risk [70, 71].
The reported changes in fat-soluble vitamins and carot-
enoids should also be placed in context of other (dietary) 
interventions where intestinal absorption of nutrients or 
carrier capacity in plasma is potentially affected. The addi-
tion of dietary fibers such as oat and barley β-glucans to the 
diet reduces serum cholesterol concentrations [72, 73] but 
have also been reported to affect fat-soluble vitamin and 
carotenoid concentrations in humans [74, 75]. Moreover, 
Kerckhoffs [76] showed a reduction of 7.2 % (P < 0.05) in 
lipid-standardized hydrocarbon carotenoid concentrations 
after consumption of 5 g/d of oat β-glucan for 2 weeks in 25 
healthy subjects. In six healthy women, adding wheat bran 
to an antioxidant mixture reduced the postprandial response 
of lycopene and lutein concentrations, while pectin, guar and 
alginate (water-soluble fibers) reduced β-carotene, lycopene 
and lutein concentrations [77]. The postprandial response of 
α-tocopherol was not changed after consumption of these 
dietary fibers, which probably relates to the lower lipophi-
licity of α-tocopherol [77]. Besides cholesterol-lowering 
foods, pharmacological intervention aimed to reduce serum 
cholesterol concentrations might also have an effect on fat-
soluble vitamin and carotenoid concentrations. HMG-CoA 
reductases inhibitors (statins) are the most frequently pre-
scribed cholesterol-lowering drugs worldwide, and reduc-
tions up to 50 % can be achieved with statin therapy [78]. 
However, despite their effects on serum cholesterol concen-
trations, concentrations of fat-soluble vitamin and carotenoid 
are not reduced. If anything, lipoprotein particles become 
enriched in vitamin/carotenoids after statin therapy [76, 79, 
80]. Another cholesterol-lowering drug is ezetimibe, which 
reduces intestinal uptake of cholesterol by acting on the 
intestinal cholesterol transporter NPC1L1 [81]. Ezetimbe is 
a relatively new approach to lower cholesterol concentrations 
and human data describing whether ezetimibe therapy has an 
effect on fat-soluble vitamin and carotenoid concentrations is 
lacking. There are, however, some indications from in vitro 
studies that ezetimibe affects the intestinal transport of carot-
enoids and that this effect decreases with increasing polarity 
of the carotenoids [82]. Other compounds that interfere with 
cholesterol absorption (i.e., neomycin), fat absorption (ole-
stra) and bile acid reabsorption (cholestyramine) have also 
been shown to reduce tocopherol and carotenoid concentra-
tions. Reported effects were at least as large or larger than 
observed for plant sterols or stanols [83–85].
The question is whether the observed changes in plasma 
fat-soluble vitamins and carotenoids during consumption of 
plant sterol or stanol ester-enriched foods can be corrected 
for? It has been indeed reported that reductions in plasma 
carotenoid concentrations can be prevented by adopting a 
healthy diet with at least five servings per day of vegetables 
and/or fruit as recommend by many guidelines for a healthy 
diet [48, 86]. For instance, the recently released AHA/ACC 
lifestyle management guidelines for healthy living empha-
size the consumption of vegetables, fruits and whole grains 
for adults who wish to lower their LDL-C concentrations 
[87]. Other guidelines like the one of the ESC/EAS also 
mention the consumption of plant sterol- and plant stanol-
enriched foods in order to further enhance the cholesterol-
lowering effect of a healthy diet [88]. Finally, consump-
tion of a cholesterol-lowering dietary portfolio, which was 
rich in plant sterols, viscous fibers, soy proteins and nuts 
for 6 months, reduced LDL-C concentrations (−13.1 %, 
CI −16.7 to −9.5 %) without affecting TC-standardized 
tocopherol and carotenoid concentrations [89]. Again, this 
demonstrates that it is possible to counteract a decrease 
in TC-standardized carotenoid concentrations after con-
sumption of plant sterol and plant stanol-enriched foods by 
changing to a recommended dietary pattern.
The current meta-analysis included study evidence 
based on a variety of experimental study designs regarding 
aspects such as duration of intervention, food products used 
and different population groups, which could have contrib-
uted to the observed heterogeneity between the studies. 
However, heterogeneity was only present in a few meas-
ured parameters with relative small I2 statistics, suggesting 
little variability between the included studies. In addition, 
we here report comparable changes in serum cholesterol 
and lipoprotein concentrations as found in previously pub-
lished meta-analyses [1–3], implying that the included 
studies in this meta-analyses are representative of all avail-
able studies in the literature that have been performed with 
plant sterols and plant stanols.
In summary, this meta-analysis including data of 41 
RCTs showed that consumption of plant sterols and plant 
stanols reduces TC-standardized hydrocarbon carot-
enoid concentrations (β-carotene, α-carotene and lyco-
pene), differently affects TC-standardized oxygenated 
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carotenoid concentrations (reduction in zeaxanthin and 
β-cryptoxanthin but not in lutein) and does not affect TC-
standardized tocopherol concentrations or absolute reti-
nol and vitamin D concentrations. Observed levels in this 
meta-analysis remained within ranges that are considered 
to be normal and there are no strong indications that the 
observed decreases have negative health implications.
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